LPC: Valeant loans rise after CEO says company to seek debt amendment

NEW YORK, Aug 9 (Reuters) - Valeant Pharmaceuticals

International's loans traded up Tuesday after the

company's chief executive officer said it would seek to modify

covenants on its $31 billion of...

Read more